Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback